Skip to main content

Technological Advances, Biologic Rationales, and the Associated Success of Chemotherapy With Hyperthermia in Improved Outcomes in Patients With Sarcoma.

Publication ,  Journal Article
Dewhirst, MW; Kirsch, D
Published in: JAMA Oncol
April 1, 2018

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

JAMA Oncol

DOI

EISSN

2374-2445

Publication Date

April 1, 2018

Volume

4

Issue

4

Start / End Page

493 / 494

Location

United States

Related Subject Headings

  • Sarcoma
  • Neoadjuvant Therapy
  • Hyperthermia, Induced
  • Humans
  • Biological Products
  • 3211 Oncology and carcinogenesis
  • 1117 Public Health and Health Services
  • 1112 Oncology and Carcinogenesis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Dewhirst, M. W., & Kirsch, D. (2018). Technological Advances, Biologic Rationales, and the Associated Success of Chemotherapy With Hyperthermia in Improved Outcomes in Patients With Sarcoma. JAMA Oncol, 4(4), 493–494. https://doi.org/10.1001/jamaoncol.2017.4941
Dewhirst, Mark W., and David Kirsch. “Technological Advances, Biologic Rationales, and the Associated Success of Chemotherapy With Hyperthermia in Improved Outcomes in Patients With Sarcoma.JAMA Oncol 4, no. 4 (April 1, 2018): 493–94. https://doi.org/10.1001/jamaoncol.2017.4941.
Dewhirst, Mark W., and David Kirsch. “Technological Advances, Biologic Rationales, and the Associated Success of Chemotherapy With Hyperthermia in Improved Outcomes in Patients With Sarcoma.JAMA Oncol, vol. 4, no. 4, Apr. 2018, pp. 493–94. Pubmed, doi:10.1001/jamaoncol.2017.4941.

Published In

JAMA Oncol

DOI

EISSN

2374-2445

Publication Date

April 1, 2018

Volume

4

Issue

4

Start / End Page

493 / 494

Location

United States

Related Subject Headings

  • Sarcoma
  • Neoadjuvant Therapy
  • Hyperthermia, Induced
  • Humans
  • Biological Products
  • 3211 Oncology and carcinogenesis
  • 1117 Public Health and Health Services
  • 1112 Oncology and Carcinogenesis